Sanofi and Regeneron’s PCSK9 inhibitor alirocumab—one of a group of antibodies heralded as the next class of cholesterol-lowering agents—has had its day in the Barcelona sun at the European Society of ...
Woman's World on MSN
Which statin is right for you? Compare meds with this handy intensity chart you'll want to save for future reference
If you have high cholesterol, there's a good chance your doctor has recommended statins to get your numbers back into a ...
New NHP data indicate robust silencing at clinically relevant dose levels and highlight potential best-in-class potency achievable with Chroma's epigenetic editors Chroma's epigenetic editor achieved ...
New research from scientists at the University of Pennsylvania shows that by tweaking the structure of the ionizable lipid component of lipid nanoparticles (LNPs), they can reduce side effects such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback